Novavax Inc to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series Transcript
Hello, everyone. Welcome back to the second webinar of this May COVID-19 series. This is Wing, the Congress Director of the World Vaccine Congresses. And thank you very much for tuning in today. And I want to take this opportunity to thank our webinar sponsor, DNA Genotek, for supporting and helping us deliver today's webinar of Novavax.
So just a gentle reminder before we kick off, you can also make questions using the control panel, please do. And we will do our best to bring these up during the Q&A. And this session is video recorded, and you will get a link to it tomorrow, 24 hours after the session.
So I'm very, very excited to have Dr. Gregory Glenn today from Novavax to present on their COVID-19 vaccine. You may have seen the news on the investment from CEPI. And he's also part of the World Vaccine Congress Scientific Advisory Board and a wonderful speaker. So we are definitely in for a very interesting session.
I know that you're all familiar with our moderator by
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
